17 min ago
UPDATE 1-FDA panel backs Bristol diabetes drug after prior rejection
By a lopsided vote of 13 to 1, an independent committee of medical experts voted on Thursday to recommend approval of a new type of diabetes drug from Bristol-Myers Squibb that U.S. regulators rejected two years ago due to safety concerns.
4 hrs ago
Experimental diabetes drug makes comeback
A panel of federal health advisers has overwhelmingly backed the benefits of an experimental diabetes drug that uses a new method to reduce blood sugar, setting aside previous concerns about the pill's safety.
8 hrs ago
Researchers Evaluating Immunotherapy Approaches for 3 Genitourinary Cancers
Researchers at the Roswell Park Cancer Institute Center for Immunotherapy are enrolling patients in three different clinical trials of novel immunotherapy approaches for treating genitourinary cancers.
Tue Dec 10, 2013
Epithelial mesenchymal transition status is associated with...
Dovitinib is a receptor tyrosine kinase inhibitor targeting fibroblast growth factor receptor and further related RTKs.
FDA staff cautious on AstraZeneca, Bristol diabetes drug
U.S. Food and Drug Administration staff said on Tuesday they were wary about the benefits versus the risks of AstraZeneca and Bristol-Myers Squibb's new diabetes drug dapagliflozin.
Fri Dec 06, 2013
Bladder Cancer in the Elderly: Balancing Disease and Surgical Risk
Of all the newly diagnosed bladder cancer patients, 25%-30% of them will have muscle-invasive disease that ideally will require major surgery in the form of a radical cystectomy, bilateral pelvic lymphadenectomy and creation of a urinary diversion as an integral part of curative therapy.
Research and Markets: Bladder Cancer Drug Pathway Analyzer 2013
There are today at least 92 targeted molecular therapies known to affect more than 210 specific intracellular signaling pathways for the treatment of bladder cancer.
Thu Dec 05, 2013
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
Wed Dec 04, 2013
What is Cancer?
The science will tell you that cancer is a disease that starts in our cells. It is when abnormal cells divide and multiply uncontrollably forming lumps or tumors or spread through the blood stream or lymphatic system.
What does your pee say about your health? New diagram shows when to...
What does your pee say about your health? New diagram shows when to be alarmed - and what you might be suffering from The Cleveland Clinic, in Ohio, has drawn up a diagram showing all of the different possible shades of urine colour and what each one means Red urine could have blood in it and this is a symptom of bladder cancer, kidney disease, ... (more)
Tue Dec 03, 2013
CDRD Ventures Inc. of Vancouver, Canada Launches New Spin-Off, Sitka Biopharma
CDRD Ventures Inc. , the commercialization vehicle of The Centre for Drug Research and Development , announced today the launch of a new spin-off company, Sitka Biopharma Inc., a biotechnology company developing a new bladder cancer treatment.
Mon Dec 02, 2013
Telormedix Raises CHF 6 Million ($ 6.6 Million) In Series B Financing Round
Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and inflammatory diseases, today announced that it has raised CHF 6 Million in an extension to its Series B financing from existing investors Aravis Venture and Proquest Investments .
Simple urine test can help diagnose 'aggressive bladder cancer'
Melbourne, Dec 01 : A new study has revealed that a simple urine test could distinguish between aggressive and low-grade bladder cancers, thus helping doctors to tailor and speed up their treatment.
Fri Nov 29, 2013
Womens Breast Milk, Kills Cancer Cells
Although the special substance, referred to as HAMLET , was discovered in breast milk many years past, it's solely currently that it's been attainable to check it on humans.
The Otago Daily Times
Loss, new products
Pacific Edge cancer diagnostic company has as expected posted a half-year trading loss, of $4.97 million yesterday, having the day previously clinched almost $29 million in additional funding from its shareholders.
Urine test could help detect aggressive bladder cancer
A simple urine test could distinguish between aggressive and less aggressive bladder cancers according to a new Cancer Research UK study published in the British Journal of Cancer .
Thu Nov 28, 2013
Cheap health insurance carries large risks
Dutch health insurance policies with the lowest premiums carry serious financial risks, according to research done by RTL News.
This is Guernsey
New test may help cancer diagnosis
A simple urine test may be able to distinguish between aggressive and low-grade bladder cancers, allowing doctors to tailor personalised treatments, say scientists.
Wed Nov 27, 2013
PE signs Cxbladder agreement with 3rd national provider-US
Pacific Edge has signed an agreement with Stratose, a large national provider network in the USA, to enable the provision of Cxbladder to patients through its large network of payers and providers.
San Francisco Firefighters Battling Alarming Cancer Rate
Flames and smoke are the visible threat but cancer is a silent killer that is claiming the lives of firefighters.